DarioHealth Corp. (DRIO) Gross margin 2016–2025
DarioHealth Corp. (DRIO) gross margin by fiscal year — reported gross profit divided by reported revenue.
56.6%FY2025 · since FY2016: -29.6% → 56.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 56.6% | +7.6 pp |
| FY2024 | 49.1% | +19.7 pp |
| FY2023 | 29.4% | -5.5 pp |
| FY2022 | 34.9% | +15.6 pp |
| FY2021 | 19.3% | -13.9 pp |
| FY2020 | 33.2% | -1.2 pp |
| FY2019 | 34.4% | +10.5 pp |
| FY2018 | 23.9% | -1.5 pp |
| FY2017 | 25.4% | +55.0 pp |
| FY2016 | -29.6% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More DRIO financial trends
DRIO RevenueDRIO Net incomeDRIO Net marginDRIO Gross profitDRIO Operating incomeDRIO Operating marginDRIO Operating cash flowDRIO Free cash flowDRIO Capital expendituresDRIO Return on equityDRIO Stock buybacksDRIO Dividends paidDRIO Total assetsDRIO Total liabilitiesDRIO Shareholders’ equityDRIO overview →